Authors
Latest:
Tessa Blanken, MSc: Identification of Robust, Clinically Relevant Insomnia SubtypesThe identification of the subtypes allows future studies to target homogeneous subtype samples, resolve inconsistencies, personalize treatment and utilize preventive interventions.
Latest:
Marc Nuwer Explores the 2019 CPT Codes for EpilepsyThe professor and vice chair of the neurology department at UCLA discussed the new VNS, RNS and DBS CPT codes for 2019.
Latest:
Joshua Cohen, MD: Fremanezumab's Impact on Quality of Life and ComorbiditiesThe Global Medical Lead for Migraine and Headache at Teva Pharmaceuticals provided insight into how fremanezumab has helped to improve these facets of the condition.
Latest:
Eight Ways to Evaluate a Telehealth VendorA look at the questions you should be asking during the decision-making process of picking a telehealth vendor.
Latest:
Zachary Grinspan, MD, MS: Collaborating Across Specialties to Improve OutcomesThe director of the Pediatric Epilepsy Program and an MD candidate at Weill Cornell Medicine detail the steps needed to take to improve outcomes in status epilepticus.
Latest:
Sharon Chiang, MD, PhD: Recording Seizures With Detection TechnologyThe neurology resident at the University of California San Francisco discussed how new wearable technology and electronic diaries have helped improve the understanding of seizure rhythmicity, and ultimately, epilepsy care.
Latest:
Screening for Alzheimer Disease: Facilitating an Early Diagnosis for Prompt InterventionIn this episode of MEDcast, expert geriatric psychiatrists explore the urgent need for effective diagnostic methods that can detect Alzheimer’s disease at an early stage. We will discuss blood-based biomarkers and other advancements that can help screen Alzheimer’s disease non-invasively and early in the disease course.
Latest:
Edward Wild, MBBChir, PhD, MA: Generation HD1 Study of RG6042The neurologist at the Huntington’s Disease Center at University College London spoke about the clinical development of RG6042 in the treatment of Huntington disease, and what to expect from the GENERATION HD1 study.
Latest:
William Tatum, DO: When to Obtain a Routine EEG While Managing a Patient with EpilepsyThe neurologist and epileptologist at the Mayo Clinic in Jacksonville spoke about how to best identify adult patients in need of routine EEG and what it will bring to the table relative to the clinician.
Latest:
Potential Promise Behind ATH434 for Multiple System Atrophy: Daniel Claassen, MD, MSThe director of the Huntington’s Disease Clinic at Vanderbilt University Medical Center gave commentary on the unique development of ATH434, its ability to target iron accumulation, and how it may slow disease progression in multiple system atrophy. [WATCH TIME: 3 minutes]
Latest:
Peter Goadbsy, MD, PhD, DSc: Atogepant Has Potential as Migraine ProphylacticThe professor of neurology at both the University of California San Francisco and King’s College, London, spoke about the results from a phase 2b/3 study evaluating atogepant for prevention of migraine.
Latest:
CNM-Au8 as a Novel Therapeutic Category in MS: Robert Glanzman, MDThe chief medical officer at Clene Nanomedicine discussed the recently presented data on CNM-Au8 from the VISIONARY-MS trial.
Latest:
Properly Integrating Newly Approved IPX203 in the Care of Parkinson DiseaseThe panelists provided clinical insight on the utilization of IPX203, its potential benefits and clinical implications, as well as the practicalities of transitioning patients from other therapies.
Latest:
Future Directions for the Management of NarcolepsyMargaret Park, MD, and Russell Rosenberg, PhD, DABSM, provide clinical pearls and the future treatment landscape for the management of narcolepsy.v
Latest:
Spinal Muscular Atrophy and COVID-19: Guidance and Resources for ProvidersAdvocacy organization Cure SMA provides guidance for health care providers caring for patients with SMA during the ongoing COVID-19 pandemic.
Latest:
Analyzing Cognitive Profiles in Multiple Sclerosis and Alzheimer Disease: Le Hua, MDThe director of the Multiple Sclerosis Program at the Cleveland Clinic’s Lou Ruvo Center for Brain Health discussed findings from a study that compared cognitive profiles between patients with multiple sclerosis and Alzheimer disease. [WATCH TIME: 5 minutes]
Latest:
Ruth Ann Marrie, MD, PhD: Role of Comorbidities in MSThe professor of medicine and community health sciences at the University of Manitoba spoke about the effects of comorbidity on diagnosis, outcomes, and treatment in multiple sclerosis.
Latest:
Practical Advice for Managing Morning OFF Episodes in Parkinson DiseaseClosing out his review of on-demand therapies for morning OFF episodes in Parkinson disease, Peter A. LeWitt, MD, shares practical advice for community neurologists.
Latest:
A Conversation on Women's Leadership and Career in Medicine: Jennifer Frontera, MDThe professor of neurology at NYU Grossman School of Medicine talked about the importance of aligning leadership roles with personal passions for women in the field of neurology pursuing their careers in medicine. [WATCH TIME: 5 minutes]
Latest:
AI-Powered Patient Advocacy: Amplifying Health Care VoicesAI could revolutionize patient advocacy by bridging communication gaps between patients and providers, and the synergy of medicine and AI offers a promising avenue for enhanced patient care and operational efficiency.
Latest:
Richard Lipton, MD: Interpreting Eptinezumab's Impact on HIT-6 ScoreThe director of the Montefiore Headache Center will provide further insight into migraine care at the 1st Annual International Congress on the Future of Neurology, to be held September 27-28 in New York City.
Latest:
Rodolfo Savica, MD, PhD: Dyskinesias in Atypical ParkinsonismThe associate professor of neurology at Mayo Clinic spoke about the findings of a population-based cohort study seeking to investigate the incidence of levodopa-induced dyskinesia in atypical parkinsonism.
Latest:
Laura Julian, PhD: The Floodlight Open MS DatabaseThe principal medical science director at Genentech spoke about the decisions behind the tools being used for measurement, and what the neurologists can get from the data.
Latest:
Laura T. Safar, MD: Carefully Addressing Mental Health in MSThe director of MS neuropsychiatry at Brigham and Women’s Hospital spoke of the importance of not oversimplifying the approach to mental health disorders in individuals with MS, and how the collaborative care model can help.­­­
Latest:
Reena Mehra, MD, MS: Advances in Sleep Apnea Treatment DevicesThe director of the Sleep Disorders Research Program at Cleveland Clinic Lerner College of Medicine detailed the advancements that have been made with OSA treatment devices.
Latest:
David Holtzman, MD: Difficulties Identifying Dementia With Lewy BodiesThe current president of the American Neurological Association specifically mentioned the work some groups are doing with small molecule imaging methods to help with this issue.
Latest:
Irina Pikuleva, PhD: Activating CYP46A1 with EfavirenzThe Carl F. Asseff Professor of Ophthalmology and the Director of the Visual Sciences Research Center at Case Western Reserve University spoke about the beginnings of her work with efavirenz.
